Glial cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling

Clinical Cancer Research

Volumn 9, Issue 6, 2003, Pages 2342-2349

  Chandrasekar, Nirmala ^a   Mohanam, Sanjeeva ^a   Lakka, S Sajani ^a   Dinh, Dzung H ^a   Olivero, William C ^a   Gujrati, Meena ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACTIN; ANGIOGENESIS INHIBITOR; GELATINASE B; METALLOPROTEINASE; METALLOPROTEINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CAPILLARY; CATTLE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOSKELETON; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; GLIA CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MORPHOGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING; ZYMOGRAPHY;

ACTINS; ANIMALS; CATTLE; CELL COMMUNICATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROGLIA; PHOSPHORYLATION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0038175081     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Lund, E. L., Spang-Thomsen, M., Skovgaard-Poulsen, H., and Kristjansen, P. E. Tumor angiogenesis-a new therapeutic target in gliomas. Acta Neurol. Scand., 97: 52-62, 1998.
2. Werb, Z., Vu, T. H., Rinkenberger, J. L., and Coussens, L. M. Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS, 107: 11-18, 1999.
3. Nagase, H., and Woessner, J. F., Jr. Matrix metalloproteinases. J. Biol. Chem., 274: 21491-21494, 1999.
4. Mignatti, P., Tsuboi, R., Robbins, E., and Rifkin, D. B. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J. Cell. Biol., 108: 671-682, 1989.
5. Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., and Weiss, S. J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell, 95: 365-377, 1998.
6. Fisher, C., Gilbertson-Beadling, S., Powers, E. A., Petzold, G., Poorman, R., and Mitchell, M. A. Interstitial collagenase is required for angiogenesis in vitro. Dev. Biol., 162: 499-510, 1994.
7. Schnaper, H. W., Grant, D. S., Stetler-Stevenson, W. G., Fridman, R., D'Orazi, G., Murphy, A. N., Bird, R. E., Hoythya, M., Fuerst, T. R., and French, D. L. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol., 156: 235-246, 1993.
8. Kraling, B. M., Wiederschain, D. G., Boehm, T., Rehn, M., Mulliken, J. B., and Moses, M. A. The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J. Cell Sci., 112: 1599-1609, 1999.
9. Puyraimond, A., Weitzman, J. B., Babiole, E., and Menashi, S. Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells. J. Cell Sci., 112: 1283-1290, 1999.
10. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., and Werb, Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell, 93: 411-422, 1998.
11. Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I. SV 40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem., 264: 17213-17221, 1989.
12. Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keski-Oja, J., and Tryggvason, K. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J. Biol. Chem., 266: 16485-16490, 1991.
13. Sato, H., and Seiki, M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8: 395-405, 1993.
14. Ennis, B. W., and Matrisian, L. M. Matrix degrading metalloproteinases. J. Neuro-Oncol., 18: 105-109, 1994.
15. Eberhardt, W., Huwiler, A., Beck, K. F., Walpen, S., and Pfeilschifter, J. Amplification of IL-1 β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-κ B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol., 165: 5788-5797, 2000.
16. Jelinek, T., Catling, A. D., Reuter, C. W., Moodie, S. A., Wolfman, A., and Weber, M. J. RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2. Mol. Cell. Biol., 14: 8212-8218, 1994.
17. Blenis, J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA, 90: 5889-5892, 1993.
18. Karin, M., and Hunter, T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol., 5: 747-757, 1995.
19. Gupta, K., Kshirsagar, S., Li, W., Gui, L., Ramakrishnan, S., Gupta, P., Law, P. Y., and Hebbel, R. P. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp. Cell Res., 247: 495-504, 1999.
20. Berra, E., Milanini, J., Richard, D. E., Le Gall, M., Vinals, F., Gothie, E., Roux, D., Pages, G., and Pouyssegur, J. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem. Pharmacol., 60: 1171-1178, 2000.
21. Gum, R., Wang, H., Lengyel, E., Juarez, J., and Boyd, D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene, 14: 1481-1493, 1997.
22. Simon, C., Goepfert, H., and Boyd, D. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res., 58: 1135-1139, 1998.
23. Lakka, S. S., Jasti, S. L., Kyritsis, A. P., Yung, W. K., Ali-Osman, F., Nicolson, G. L., and Rao, J. S. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades. Clin. Exp. Metastasis, 18: 245-252, 2000.
24. Genersch, E., Hayess, K., Neuenfeld, Y., and Haller, H. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J. Cell Sci., 113: 4319-4330, 2000.
25. Nirmala, C., Jasti, S. L., Sawaya, R., Kyritsis, A. P., Konduri, S. D., Ali-Osman, F., Rao, J. S., and Mohanam, S. Effects of radiation on the levels of MMP-2. MMP-9 and TIMP-1 during morphogenic glial-endothelial cell interactions. Int. J. Cancer, 88: 766-771, 2000.
26. Rao, J. S., Sawaya, R., Gokaslan, Z. L., Yung, W. K., Goldstein, G. W., and Laterra, J. Modulation of serine proteinases and metalloproteinases during morphogenic glial-endothelial interactions. J. Neurochem., 66: 1657-1664, 1996.
27. Frost, J. A., Geppert, T. D., Cobb, M. H., and Feramisco, J. R. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc. Natl. Acad. Sci. USA, 91: 3844-3848, 1994.
28. Rao, J. S., Steck, P. A., Tofilon, P., Boyd, D., Ali-Osman, F., Stetler-Stevenson, W. G., Liotta, L. A., and Sawaya, R. Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J. Neuro-Oncol., 18: 129-138, 1994.
29. Redlitz, A., Daum, G., and Sage, E. H. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells. J. Vasc. Res., 36: 28-34, 1999.
30. Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., de Lanerolle, P., and Cheresh, D. A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol., 137: 481-492, 1997.
31. Tanaka, K., Abe, M., and Sato, Y. Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Jpn. J. Cancer Res., 90: 647-654, 1999.
32. Chu, C. L., Reenstra, W. R., Orlow, D. L., and Svoboda, K. K. Erk and PI-3 kinase are necessary for collagen binding and actin reorganization in corneal epithelia. Investig. Ophthalmol. Vis. Sci., 41: 3374-3382, 2000.
33. Rikitake, Y., Kawashima, S., Yamashita, T., Ueyama, T., Ishido, S., Hotta, H., Hirata, K., and Yokoyama, M. Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway. Arterioscler. Thromb. Vasc. Biol., 20: 1006-1012, 2000.
34. Stefanik, D. F., Rizkalla, L. R., Soi, A., Goldblatt, S. A., and Rizkalla, W. M. Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res., 51: 5760-5765, 1991.
35. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
36. Jung, Y. D., Nakano, K., Liu, W., Gallick, G. E., and Ellis, L. M. Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. Cancer Res., 59: 4804-4807, 1999.
37. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954, 1991.
38. El Dahr, S. S., Dipp, S., and Baricos, W. H. Bradykinin stimulates the ERK->Elk-1->Fos/AP-1 pathway in mesangial cells. Am. J. Physiol., 275: F343-F352, 1998.
39. Milanini, J., Vinals, F., Pouyssegur, J., and Pages, G. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J. Biol. Chem., 273: 18165-18172, 1998.
40. Xu, L., Fukumura, D., and Jain, R. K. Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway. Mechanism of low ph-induced VEGF. J. Biol. Chem., 277: 11368-11374, 2002.
41. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80: 179-185, 1995.
42. Bennett, A. M., and Tonks, N. K. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science (Wash. DC), 278: 1288-1291, 1997.
43. Jiang, B., Bezhadian, M. A., and Caldwell, R. B. Astrocytes modulate retinal vasculogenesis: effects on endothelial cell differentiation. Glia, 15: 1-10, 1995.
44. Ilan, N., Mahooti, S., and Madri, J. A. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J. Cell Sci., 111: 3621-3631, 1998.
45. Maru, Y., Yamaguchi, S., Takahashi, T., Ueno, H., and Shibuya, M. Virally activated Ras cooperates with integrin to induce tubulogenesis in sinusoidal endothelial cell lines. J. Cell Physiol., 176: 223-234, 1998.
46. Eliceiri, B. P., Klemke, R., Stromblad, S., and Cheresh, D. A. Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol., 140: 1255-1263, 1998.
47. Chandrasekar, N., Jasti, S., Alfred-Yung, W. K., Ali-Osman, F., Dinh, D. H., Olivero, W. C., Gujrati, M., Kyritsis, A. P., Nicolson, G. L., Rao, J. S., and Mohanam, S. Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions. Clin. Exp. Metastasis, 18: 337-342, 2000.
48. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond.), 369: 156-160, 1994.
49. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., and Davis, R. J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem., 270: 7420-7426, 1995.
50. Chen, R. H., Juo, P. C., Curran, T., and Blenis, J. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene, 12: 1493-1502, 1996.
51. Murphy, A. N., Unsworth, E. J., and Stetler-Stevenson, W. G. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell Physiol., 157: 351-358, 1993.
52. Lamoreaux, W. J., Fitzgerald, M. E., Reiner, A., Hasty, K. A., and Charles, S. T. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc. Res., 55: 29-42, 1998.